Petra Minarikova
Overview
Explore the profile of Petra Minarikova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitrova K, Cerna K, Zdychyncova K, Pipek B, Svikova J, Minarikova P, et al.
Eur J Pediatr
. 2024 Jul;
183(10):4243-4251.
PMID: 39023645
Evidence on serological responses to vaccination in children exposed to ustekinumab (UST) or vedolizumab (VDZ) in utero is lacking. This multicentre prospective study aimed to assess the impact of prenatal...
2.
Kucerka O, Blahutova M, Kosek V, Minarikova P, Horacek J, Urbanek P, et al.
Metabolites
. 2024 Apr;
14(4).
PMID: 38668313
Inflammatory bowel disease, encompassing Crohn's disease and ulcerative colitis, is a persistent immune-mediated inflammatory gastrointestinal disease. This study investigates the role of growth differentiation factor 15 in severe IBD cases,...
3.
Wasserbauer M, Hlava S, Drabek J, Stovicek J, Minarikova P, Nedbalova L, et al.
PLoS One
. 2022 Aug;
17(8):e0271299.
PMID: 35939424
Objective: The adalimumab biosimilars FKB327 and GP2017 were approved for the therapy of patients with inflammatory bowel disease (IBD). Relatively few prospective studies with biosimilar adalimumab in patients with IBD...
4.
Mitrova K, Pipek B, Bortlik M, Bouchner L, Brezina J, Douda T, et al.
J Crohns Colitis
. 2022 Jun;
16(12):1808-1815.
PMID: 35708729
Background And Aims: Evidence on the safety of newer biologics during pregnancy is limited. We aimed to assess the safety of ustekinumab and vedolizumab treatment during gestation on pregnancy and...
5.
Vojtechova G, Benesova L, Belsanova B, Minarikova P, Levy M, Lipska L, et al.
Adv Clin Exp Med
. 2016 Dec;
25(6):1273-1279.
PMID: 28028983
Background: The presence of circulating tumor cells (CTC) has been reported in patients with advanced colorectal cancer. Monitoring CTC (also known as a liquid-biopsy) has recently become the center of...
6.
Minarikova P, Benesova L, Halkova T, Belsanova B, Tuckova I, Belina F, et al.
Gastroenterol Res Pract
. 2016 Oct;
2016:9408190.
PMID: 27781065
. Gastric cancer is known for a notable variety in the course of the disease. Clinical factors, such as tumor stage, grade, and localization, are key in patient survival. It...
7.
Suchanek S, Grega T, Ngo O, Vojtechova G, Majek O, Minarikova P, et al.
World J Gastroenterol
. 2016 Oct;
22(36):8103-11.
PMID: 27688652
The incidence and prevalence of metabolic syndrome (MS) and colorectal cancer (CRC) has been rising in developed countries. The association between these two diseases has been widely studied and reported....
8.
Minarikova P, Benesova L, Halkova T, Belsanova B, Suchanek S, Cyrany J, et al.
World J Gastroenterol
. 2016 May;
22(20):4936-45.
PMID: 27239120
Aim: To compare molecular profiles of proximal colon, distal colon and rectum in large adenomas, early and late carcinomas. To assess feasibility of testing directed at molecular markers from this...
9.
Zavoral M, Suchanek S, Majek O, Fric P, Minarikova P, Minarik M, et al.
World J Gastroenterol
. 2014 Apr;
20(14):3825-34.
PMID: 24744575
Colorectal cancer (CRC) is the second most common cancer in Europe and its incidence is steadily increasing. This trend could be reversed through timely secondary prevention (screening). In the last...
10.
Suchanek S, Majek O, Vojtechova G, Minarikova P, Rotnaglova B, Seifert B, et al.
Eur J Cancer Prev
. 2013 Oct;
23(1):18-26.
PMID: 24129196
The incidence and mortality of colorectal cancer (CRC) in the Czech Republic is significant. The National CRC Screening Program started in 2000 and was further enhanced in 2009. In 2010,...